Risk stratification of pancreatic neuroendocrine neoplasms based on clinical, pathological, and molecular characteristics

JH Choi, WH Paik - Journal of Clinical Medicine, 2022 - mdpi.com
Pancreatic neuroendocrine neoplasms consist of heterogeneous diseases. Depending on
the novel features detected by various modern technologies, their classification and related …

Changes in categorization or nomenclature within neuroendocrine tumors

GV Trucco, M Volante - Endocrine-Related Cancer, 2024 - erc.bioscientifica.com
Graphical abstract Abstract The 5th edition of the World Health Organization (WHO)
classification of neuroendocrine neoplasms (NENs) is built to achieve a uniform terminology …

Position statement on the diagnosis, treatment, and response evaluation to systemic therapies of advanced neuroendocrine tumors, with a special focus on …

J Capdevila, E Grande, R García-Carbonero… - The …, 2022 - academic.oup.com
Background The aim of this study was to provide a guidance for the management of
neuroendocrine tumors (NETs) in clinical practice. Material and Methods Nominal group and …

Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic …

P Mapelli, C Bezzi, F Muffatti, S Ghezzo… - European Journal of …, 2023 - Springer
Purpose To evaluate the role of 68Ga-DOTATOC PET parameters in predicting DAXX/ATRX
loss of expression in patients with Pancreatic neuroendocrine tumors (PanNET) candidate to …

[Retracted] Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of …

A Sadula, G Li, D Xiu, C Ye, S Ren… - … Methods in Medicine, 2022 - Wiley Online Library
Background. The incidence of nonfunctional pancreatic neuroendocrine neoplasms (NF‐
pNENs) has been increasing annually. This study is aimed at investigating the …

Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next …

EM Ghabi, JR Habib, S Shoucair, AA Javed… - Annals of surgical …, 2023 - Springer
Abstract Background Pancreatic neuroendocrine tumors (PanNETs) exhibit heterogenous
behavior, whereby some small tumors are aggressive with a propensity for metastasis …

[HTML][HTML] Clinical and genomic analyses of neuroendocrine neoplasms of the breast

Y Wei, X Ke, J Yu, Q Jing, H Bu, X Zeng, B Wei - Modern Pathology, 2022 - Elsevier
Breast neuroendocrine neoplasms (NENs) constitute a rare histologic subtype that includes
both neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs). In this study …

Enhancer of zeste homolog 2 (EZH2) is a marker of high-grade neuroendocrine neoplasia in gastroenteropancreatic and pulmonary tract and predicts poor prognosis

SCB Bremer, G Bittner, O Elakad, H Dinter, J Gaedcke… - Cancers, 2022 - mdpi.com
Simple Summary Neuroendocrine neoplasms most frequently arise in the
gastroenteropancreatic and pulmonary tract and show an increasing incidence and …

Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm …

J Chen, P Wang, K Lv, W Zhou - Diagnostic Pathology, 2021 - Springer
Background Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) of the
pancreas are extremely rare. Their pathogenesis and molecular landscape are largely …

State of the art and future directions in the systemic treatment of neuroendocrine neoplasms

C Jungels, A Deleporte - Current Opinion in Oncology, 2021 - journals.lww.com
State of the art and future directions in the systemic treat... : Current Opinion in Oncology State
of the art and future directions in the systemic treatment of neuroendocrine neoplasms …